Teva Pharmaceuticals USA
Headquarters country
United States
Registry sponsor category
Industry
- Other names
- Teva Pharmaceuticals USA
- Company name
- Teva Pharmaceuticals USA
- Organisation type
- Industry
- Registered legal name
- TEVA PHARMACEUTICALS USA, INC.
- Registry sponsor category
- Industry
- Legal Entity Identifier (LEI)
- 54930009E6JHZUIRO925
Related records
Trials (233)
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Fasting Conditions.
- 10 mg Donepezil Hydrochloride Orally Disintegrating Tablets Under Non-Fasting Conditions
- 15 mg Mirtazapine Orally Disintegrating Tablets, Fasting
- 15 mg Mirtazapine Orally Disintegrating Tablets, Non-Fasting
- 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting
- 5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting
- 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fasting Conditions
- 600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions
- 90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions
- 90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions
- A Clinical Endpoint Bioequivalence Study of "Oxymetazoline Hydrochloride Cream"
- A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
- A Multicenter Observational Study to Evaluate Pediatric Multiple Sclerosis in Brazil
- A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
- A Prospective, Multicenter, Open-label 12 Week Neoadjuvant Phase II Trial Optimizing Taxane Therapy in Elderly Patients With Low Response
- A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp
- A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Fasting Conditions
- A Relative Bioavailability Study of 200mg/5 mL Azithromycin Oral Suspension Under Non-Fasting Conditions
- A Study Evaluating the Pain Palliation Benefit of Adding Custirsen to Docetaxel Retreatment or Cabazitaxel as Second Line Therapy in Men With Metastatic Castrate Resistant Prostate Cancer (mCRPC)
- A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering